Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
China's strength in health sector important for Africa: Global Fund chief

Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Sunday hailed the organization's health cooperation with China. Speaking to Xinhua in an exclusive interview on the sidelines of the 32nd African Union summit, Sands said the fund has been working with the Chinese government in the treatment and prevention of AIDS, tuberculosis and malaria.

Published
12 February 2019
From
Xinhua
Tenofovir Alafenamide Linked to Fanconi Syndrome

This case study is presented as a caution to clinicians that tenofovir alafenamide can cause Franconi Syndrome.

Published
12 February 2019
From
Infectious Disease Advisor
Trump’s goal to eradicate the HIV epidemic in the United States is achievable — yet remote

The president’s pledge rings hollow without a major shift in policy and rhetoric.

Published
12 February 2019
From
Nature (editorial)
Low testosterone persists after HCV clearance

Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.

Published
12 February 2019
From
Healio
Correlation between HIV, rectal gonorrhea could help PrEP trial designs

Rectal gonorrhea incidence may serve to estimate what HIV incidence would have been had trial participants not received PrEP, according to study findings.

Published
12 February 2019
From
Healio
The European AIDS Treatment Group names new Executive Director

The European AIDS Treatment Group (EATG) is delighted to introduce our new Executive Director, Pieter Vanholder.

Published
11 February 2019
From
EATG
‘Gag rule’ threatens to restrict women’s access to a highly effective HIV therapy

As we wait for more evidence about the safety of dolutegravir during pregnancy, the solution is simple: ensure that women living with HIV have access to contraception so they can benefit from this medication. But that has become an often-insurmountable problem due to the global gag rule.

Published
11 February 2019
From
STAT
To Halt HIV, Advocates Push For PrEP Outreach To Black Women

In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Not much happened.

Published
11 February 2019
From
NPR
Trading in Venezuela's pain: Border vendors do brisk business in meds

With the HIV virus killing him, Giovanni Plaza fled Venezuela and was able in neighboring Colombia to receive desperately needed anti-retroviral medicine for free. Some of his compatriots have not been as lucky -- reduced to buying smuggled drugs of dubious quality.

Published
11 February 2019
From
France 24
A Cure for HPV? Not So Fast…

Can photodynamic therapy eliminate the virus than causes cervical, anal and oral cancer?

Published
11 February 2019
From
Poz

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.